Immediate Impact

69 standout
Sub-graph 1 of 23

Citing Papers

Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Prevalence of cancer survivors in the United States
2024 Standout
2 intermediate papers

Works of Luke Velders being referenced

Association of cyclophosphamide drug–metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors
2009
Validation and Psychometric Assessment of a Short Clinical Scale to Measure Chemotherapy-Induced Nausea and Vomiting: The MASCC Antiemesis Tool
2007

Author Peers

Author Last Decade Papers Cites
Luke Velders 143 109 112 6 324
Helen G. Mulholland 103 114 102 10 321
Yoko Ohba 132 169 27 11 364
G. Amyotte 53 81 22 4 282
Ö. Karaçay 56 38 104 6 368
Z. Kerestes 80 49 23 8 315
Philippos Kaldrymides 43 78 66 12 365
Nobuyuki Hamajima 75 144 67 7 339
Heidi H. Jackson 131 52 30 9 356
A-M Ugnat 55 107 83 7 366
Cristina Bellati 100 119 69 7 347

All Works

Loading papers...

Rankless by CCL
2026